As we enter into the 21st century, infectious disease specialists will be managing a greater number and proportion of patients with infections who are §65 years old. Much has been learned about aging, host resistance, and infections over the past 15 years. However, if we are to meet the challenge of the complex issues of geriatric infectious diseases, infectious disease clinicians, teachers, and researchers must assume a more proactive role in clinical care, training, education, and research on problems and issues confronting the aging population.
In 1982, Dr. Paul Beeson, a pioneer in the field of infectious ated with immune senescence (now more commonly termed immune dysregulation) [3 -6] and, most likely, explained the diseases and then editor of the Journal of the American Geriatrics Society, was kind enough to invite me to write my perspecclinical observations of higher prevalence, morbidity, and mortality of certain infections in the elderly (table 1) and the poorer tive on the new and emerging problem of geriatric infectious diseases (GID) [1] . Now 15 years later, I am pleased and responses to vaccination with old age [7 -15] . However, despite this wealth of new information up to the early 1980s, much privileged to provide a brief overview of the field of GID during the period 1982 -1997, as well as give my perspectives remained to be understood about the impact of aging on risk, etiology and severity of infections, the underlying pathogenetic on the future direction of aging and infectious diseases.
mechanisms of immune dysregulation, differences in clinical manifestations of infection with age, and how aging affects Past antimicrobial therapy. As early as the late 19th and beginning of the 20th century, the interrelationship of aging, immunity, and infections was Present recognized by Elie Metchnikoff, the discoverer of cellular immunity. Metchnikoff developed the first theory of aging based Over the past 15 years, a substantial amount of information on infection and immune dysregulation [2] . He reasoned that has been accumulated about gerontoimmunology, GID, and certain intestinal microbes were responsible for chronic toxin geropharmacology. It is clear now that aging has its greatest production, and these toxins activated macrophages to attack impact on cell-mediated immunity, with a lesser but substantial the body's own tissue (i.e., a form of autoimmunity). Metchnieffect on humoral immune function [16 -18] . Cytokine synthekoff advocated replacing the indigenous intestinal microflora sis or activity (e.g., interleukin-1 [IL-1], IL-2, IL-6) or cytokine with lactobacilli, which would inhibit toxin-producing organreceptors may be adversely affected by age. The pathogenetic isms and thus retard the aging process [2] . A temporary but mechanisms of these abnormalities are being elucidated, with fervent popularity of fermented milk products, particularly yoevidence indicating defects in mRNA expression as well as gurt, in Europe was an outcome of Metchnikoff's theory of signal transduction [19 -21] . More recently, preliminary data aging.
suggest that cytokine antagonists (IL-1 receptor antagonist and However, there was a paucity of scientific data on the associsoluble tumor necrosis factor [TNF]) are elevated in plasma of ations of aging, host resistance and defenses, and GID until healthy elderly compared with healthy younger adults. The late 1960s and early 1970s. With an awareness of a rapidly increase in cytokine antagonists results in reduced production growing number of elderly persons and an increase in life of IL-2, which decreases T cell proliferation [22] . When elderly expectancy of people from developed countries, research in patients with urinary tract infections were examined, their levgerontology (study of aging) and geriatrics (care of the elderly), els of cytokine antagonists were substantially higher than those including gerontoimmunology and GID, began to flourish.
in the healthy elderly, suggesting that inapparent or subclinical Such investigations indicated that aging was definitely associinfections in the latter group might account for immune suppression [22] . The data on the association of aging with macrophage and neutrophil function are less clear. Studies on the impact of old with endemic drug-resistant mycobacteria), and thus most older † For renal infection.
patients with this infection can be treated with isoniazid and ‡ Excluding human immunodeficiency virus -infected younger adults.
rifampin for 9 months, rather than the four-drug regimen advocated by the American Thoracic Society and Centers for Disease Control and Prevention [45] . young mice [24] . However, whether aging adversely influences microbicidal activities of macrophages is unknown. Similarly, UTI is the most common bacterial infection in older adults, and in contrast to younger adults, in whom UTI is a disease there is a lack of consensus -despite numerous studies -on whether the neutrophils of older adults function normally primarily of sexually active women, UTI occurs frequently in both elderly women and men [46, 47] . However, the vast majoragainst microbial invasion [25 -30] . Investigations have shown specific or isolated defects along the pathway of neutrophil ity of UTIs in the elderly are asymptomatic [48, 49] . Nevertheless, asymptomatic UTI is a true infection -as evidenced by function (e.g., chemotaxis, phagocytosis, microbicidal events), but it is unproven whether these findings translate into clinically a host inflammatory response (pyuria or presence of urinary cytokines) [50] . Despite this evidence, antimicrobial therapy is relevant abnormalities.
The clinical manifestations of diseases in the elderly may not recommended for the majority of elders with asymptomatic UTI [51]. Short-course (e.g., 3 days) treatment is not recombe altered (i.e., atypical, nonspecific, absent). These alterations may be due to aging or associated underlying diseases. Aged mended for older patients with symptomatic UTI; a standard 7 -14 days of therapy is suggested [47] . patients with infection may fail to exhibit a febrile response [31] . Animal investigations suggest that one potential explanaInfections in long-term care facilities (LTCFs) such as a nursing home (now called nursing facility) is an important tion for depressed temperature responses with age is altered responses to pyrogenic cytokines (IL-1, IL-6, TNF) [32 -34] .
domain of GID. Pneumonia, UTI, and skin and soft tissue infections (''pus'') constitute Ç75% of infectious diseases in However, it is also clear that some frail elderly may elicit a robust temperature elevation when infected, but the temperature LTCFs [52, 53] . Tuberculosis in LTCFs is a serious medical and public health problem and accounts for nearly 20% of all fails to reach the criterion for ''fever'' (e.g., 38ЊC); these elders have a lower-than-normal baseline core body temperature [35] .
cases of this infection in the elderly [54, 55] . Methicillinresistant Staphylococcus aureus has been a major problem in Consequently, it has been recommended that a rise in body temperature in elderly persons (e.g., 2ЊF or 1ЊC) in the approLTCFs [56, 57] , and more recently, clinicians are reporting that vancomycin-resistant enterococci have begun to emerge priate clinical setting be one criterion for fever [36] .
Cognitive impairment, primarily as delirium or acute confuin LTCFs [58] . Much has been learned about the appropriate selection and sional state, is a very common mode of presentation of elderly patients with infections [37] . Conversely, infections are often dosing of antimicrobial agents from numerous pharmacologic studies and clinical trials [59] . For most serious infections in the most frequent causes of delirium in elders. The absence of symptoms in the presence of active infection is not unusual in elderly patients, b-lactam antibiotics should be considered as first-line therapy because of their efficacy, favorable pharmacoolder persons harboring an infectious disease, such as asymptomatic urinary tract infection (UTI) [38] .
kinetics (high serum levels, infrequent dosing), lack of need for measuring serum concentrations, and safety [60] . Because of growing interest in GID, there is a substantial number of clinical studies of a variety of infectious diseases
Immunizations with tetanus toxoid, influenza, and pneumococcal vaccines are recommended for elderly persons [61] . The in the geriatric population. Some of the salient findings from this large volume of literature will be briefly summarized.
incidence of tetanus, which is relatively low in the United States, significantly increases with age, largely due to inadeHow do we best address these and other GID problems? Although there has been a rapidly developing interest and inquate immunizations (including booster doses). Although the rates of influenza in the elderly are not especially high, the crease in number of trainees entering the field of gerontology and geriatrics, there remains a critical shortage of academic majority of influenza-related deaths (75%) occur in this population [61] . There is not a unanimity of opinion on the efficacy geriatricians [65] . Furthermore, the majority of academic geriatricians lack the skills and training in immunology and infecof the pneumococcal vaccine in elderly persons [62, 63] . Nevertheless, the prevailing opinion and recommendation are to adtious diseases to pursue these complex GID problems. I believe the time has come for infectious disease clinicians, educators, minister the vaccine to all persons §65 years old.
and researchers, as well as infectious disease professional organizations, to take a more proactive role in addressing and solving many of the issues in GID. Several potential pathways and Future approaches to achieve this objective include the following:
• Adult infectious disease fellowship training programs As we move into the next millennium, infectious disease specialists can expect to see a greater number of elderly patients should have a curriculum emphasizing the biology of aging (especially immune changes with aging), geriatric pharmacolin their clinical practice. With the aging of the ''baby boomers,'' it is projected that the current number of Ç33 million ogy, and unique aspects of infections in the elderly (epidemiology, clinical manifestations, diagnostic approach, treatment, Americans §65 years old will double by the year 2030 [64] .
What are the important GID problems and issues that will prognosis, and prevention).
• Continuing medical education courses and conferences on confront us in the immediate future, as well as the next 25 -30 years? What is the best strategy to address these issues?
infectious diseases should regularly include topics addressing the special problems of GID. Because of space limitation it is not feasible to provide a complete list of important issues in aging and infectious dis-
• The Infectious Diseases Society of America should consider having a special category of ''Aging'' for abstract presentation eases. The following are a few areas of concern in GID that need further investigation and resolution:
at its annual scientific meeting (much like the national meeting of the American Federation for Medical Research).
• Determine the quantitative impacts of immune dysregulation on the susceptibility to and recovery from infectious dis-
• Journals oriented exclusively to infectious diseases should feature a section regularly devoted to infectious disease issues eases, that is, how much influence does aging really have on the risk and outcome to infections?
and problems of the elderly (some journals have already assumed this practice). Research papers focusing on aging and • Elucidate more precise definitions of subcellular and molecular mechanisms causing immune dysregulation in order to host resistance or host response to infections as well as GID should be actively solicited by infectious disease journals. Indevelop potential therapeutic interventions.
• Develop a simple, accurate, noninvasive, and inexpensive fectious disease textbooks should have a special chapter on aging and infectious diseases. method to determine the microbial etiology of pneumonia in the elderly (currently õ20% of elderly pneumonia cases have
• Funding agencies for infectious disease and infectious disease -related research (e.g., National Institute for Allergy and a specific etiologic diagnosis).
• Define the pathogenetic mechanisms of chronic asymptomInfectious Diseases) should allocate specific dollars for basic, clinical, epidemiologic, and health services research focused atic bacteriuria in noncatheterized older adults (which would then lead to potential intervention strategies).
on basic mechanisms of diseases and host resistance with aging; diagnosis, treatment and prevention of infections in the elderly; • Find innovative methods and techniques that prevent, reduce, or eliminate microbial (primarily bacterial and yeast) innovative approaches to improving administration and outcome of antimicrobial therapy in frail, sick elderly; models of colonization of chronic bladder catheters on a long-term basis.
• Investigate newer approaches of intervention that reduce delivery of infectious disease care in older people; and methods to improve the efficacy of vaccines in elderly persons. the mortality and morbidity of gram-negative bacillary sepsis in elderly patients.
Infectious disease specialists have always successfully met infectious disease challenges that threatened the health and • Establish more sensitive and specific as well as simple, rapid, and inexpensive methods to screen for tuberculosis. (The public health of our society (e.g., toxic shock syndrome, legionnaire's disease). We are now in the midst of our yet biggest tuberculin skin test in the elderly is subject to high rates of false-negative reactions.) challenge, HIV infection. However, over the next quarter century, the problems of aging and infections will be equally if • Clarify the role of or necessity for prophylactic antibiotics for elderly persons who have prosthetic devices, especially not more daunting than those of HIV infections. I hope that we, as infectious disease specialists, will face our newest chaljoint prosthesis, or undergo dental or other invasive procedures.
• Develop strategies that will improve the efficacy of both lenge and seize the opportunity to become major contributors to the health and well-being of the largest segment of our influenza and pneumococcal vaccines in the elderly (e.g., immune modulators).
population, the aging adult.
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